1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

Körber Signs Strategic Agreement with Anrate to Implement the Factory of Excellence

09 Jul 2024
Admin
News Article

Körber Signs Strategic Agreement with Anrate to Implement the Factory of Excellence

Körber signs strategic agreement with Anrate to implement the factory of excellence in the pharmaceutical industry

Overview

Körber, an international technology group, signed a comprehensive strategic cooperation agreement with Tonghua Anrate Biopharmaceutical Co., Ltd., a pioneering biopharmaceutical company headquartered in China. Wei Xiang, managing director of Anrate, and Jerry Zheng, managing director China of Körber Business Area, among others, attended the signing ceremony.

Regarding the Agreement

According to the agreement, Körber will provide Anrate with a series of smart manufacturing and digital transformation solutions, including but not limited to fully automated pharmaceutical machines, production software, digital solutions, comprehensive training as well as technical support services.
These solutions will further enhance Anrate's Factory of Excellence level in regards of management operations.
By introducing Werum PAS-X MES and Werum PAS-X Savvy, Anrate is expected to build a smart factory that balances compliance and efficiency, achieving interconnection of software and hardware data in all stages of pharmaceutical production, accelerating the company's digital process, thereby promoting high-quality sustainable development in the industry.

Words from MS: Anrate

Wei Xiang, managing director of Anrate expressed with joy: ""On the occasion of Anrate's tenth anniversary, we are very pleased to have a comprehensive and in-depth cooperation with Körber, whose solutions have unique innovative awareness and industry's best practice experience. We look forward to leveraging the complementary strengths of both parties to provide strong technical support for Anrate's development."

About Anrate

As a leading representative of the biopharmaceutical industry, Anrate has always regarded digital and intelligent construction as one of the company's core strategies.
The signing of this strategic cooperation agreement will enable Anrate to leverage Körber's continuous technological innovation and solutions since 1895 in the pharmaceutical industry to further enhance the company's smart factory level and manufacturing efficiency.

Statement from the Körber Business Area

"Technology-assisted is the future direction of pharmaceutical development. Our solutions not only focus on the factory level but also take into account the special requirements of regulatory agencies and the pharmaceutical industry itself," said Jerry Zheng, managing director China of Körber Business Area,
"We are firmly convinced that together we can further establish the concept of the "Factory of Excellence" in the pharmaceutical industry and thus create a technological breakthrough that will stand for efficiency and future orientation."

Step Towards the Smart Manufacturing

The signing of this strategic agreement is an important step for Anrate towards smart manufacturing and also another important investment by Körber in the Chinese market. "New Quality Productivity"" is a new goal of industrial manufacturing advocated by the Chinese government.
Körber and Anrate will work together to achieve intelligence, efficiency, and green production in the biopharmaceutical industry, and strive to set an example of smart manufacturing in the Chinese pharmaceutical industry.

About Körber

Körber is an international technology group with more than 12,000 employees at over 100 locations worldwide and a common goal: The company turn entrepreneurial thinking into customer success and shape the technological change.

Tonghua Anrate Biopharmaceutical Co., Ltd.

Established in 2014, Tonghua Anrate Biopharmaceutical Co., Ltd., is a high-tech biopharmaceutical company integrating research and development, production and manufacturing, with international advanced process technology and rich R&D experience.